Unlike other hemophilia therapies, Qfitlia is indicated for both hemophilia A and B, and can be given in patients regardless ...

Equities researchers at William Blair issued their FY2028 earnings estimates for Tempest Therapeutics in a research report ...

Shares of AI software company Palantir Technologies (PLTR) fell today, even after investment firm William Blair said that the ...

William Blair analyst Louie DiPalma says the U.S. Army changed course and put the Army Data Platform 2.0 program on indefinite hold. In 2023, ...

Stock analysts at William Blair issued their Q1 2025 EPS estimates for Neurogene in a research report issued to clients and ...

Fintel reports that on March 25, 2025, William Blair initiated coverage of Immunic (NasdaqGS:IMUX) with a Outperform ...

Fintel reports that on March 26, 2025, William Blair initiated coverage of StoneX Group (NasdaqGS:SNEX) with a Outperform ...

Tesla shares fell more than 5% on Wednesday, ending the EV maker's blistering rebound out of a prolonged slump.

Lululemon stock fell 15% in afternoon trading after CEO Calvin McDonald said consumers are beginning to spend less in ...

Investing.com -- William Blair remains optimistic on Tesla (NASDAQ: TSLA) despite recent setbacks, forecasting that shares ...